Paraptosis indicted by Calpeptin is due to CHAC1 mediated glutathione degradation in glioma cells

Authors: Sun, Yuxue; Chen, Yong; Huang, Haiyan; Zhan, Zhixin; Zhang, Chaochao; Lai, Jiacheng; Li, Chaoyue; Liu, Ziqiang

Source journal: American journal of cancer research (2026-01-01)

DOI: 10.62347/FHSG2216

Abstract

Glioma is the most common form of malignant tumor of the central nervous system and has a poor prognosis. This study aimed to determine whether calpeptin (CP), an inhibitor of calpains, induces paraptosis in glioma cells, involving programmed cell death independent of caspase activation. We found that CP induced vacuole formation in the cytoplasm of T98G and LN18 glioma cells. An endoplasmic reticulum (ER) fluorescent probe showed that vacuole formation was due to ER swelling. CP induced ER stress and mitochondrial dysfunction, causing increased production of reactive oxygen species (ROS) and inhibition of mitochondrial membrane potential with activation of the PARP1 and MAPK signaling pathways. The oxygen consumption rate assay (OCR) showed that CP reduced mitochondrial oxidative phosphorylation in T98G cells. Furthermore, CP caused the release of Ca(2+) in the ER of glioma cells into the cytoplasm and destroyed intracellular Ca(2+) homeostasis. However, the ER stress inhibitor 4-PBA, the antioxidant N-acetylcysteine, the PARP-1 inhibitor benzamide, the MAPK inhibitors U0126, SP600125 and SB203580, and the Ca(2+) inhibitor 2-APB did not block CP-induced paraptosis. Finally, we found that the addition of glutathione (GSH) to the medium blocked CP-induced paraptosis. By sequencing the transcriptome, we identified CHAC1 as a key factor involved in GSH metabolism that was significantly up-regulated by CP. Knocking out CHAC1 prevented CP-induced paraptosis, and we concluded that glutathione degradation caused by CHAC1 up-regulation is the crucial mechanism underlying CP-induced paraptosis. Taken together, our findings provide novel insights into the treatment of gliomas through paraptosis induced by CP.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.